Indian Journal of Pharmacy Practice logo
Article

Diffuse Systemic Sclerosis with Interstitial Lung Disease and Severe Pulmonary Arterial Hypertension: A Case Report

1, 1, 1, 1, 1, 2, 2

  1. 1Department of Pharmacy Practice, BLDEAs SSM College of Pharmacy and Research Centre, Vijayapura, Karnataka, INDIA.
  2. 2Department of Medicine, Shri B M Patil Medical College Hospital and Research Centre, Vijayapura, Karnataka, INDIA.

CORRESPONDENCE

Syed Zia Inamdar

Department of Pharmacy Practice, BLDEAs SSM College of Pharmacy and Research Centre, Vijayapura, Karnataka, INDIA.

syedzia.inamdar@gmail.com

Volume 15, Issue 4 · pp. 338-341 · 2022 · DOI: 10.5530/ijopp.15.4.62

ABSTRACT

Systemic sclerosis is a rare connective tissue disease categorized by extensive lung fibrosis, vascular and immunologic abnormalities. Autoimmune antibodies like anticentromere, anti-Scl-70 (anti-topoisomerase I), and anti-RNA polymerase II are commonly involved in progressive disease. Clinical presentations consist of Raynaud’s phenomenon, digital ulcers; pericardial effusion, and telangiectasia and are mostly associated with pulmonary complications like interstitial lung disease and pulmonary arterial hypertension. Disease-specific therapy is unavailable instead; symptomatic management is only the line of treatment. We report here a case of diffuse systemic sclerosis with interstitial lung disease and pulmonary arterial hypertension.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Inamdar, S. Z., Londhe, S., Mehta, R., Katageri, S., Biradar, S., Devaramani, S., & Badiger, S. (2022). Diffuse Systemic Sclerosis with Interstitial Lung Disease and Severe Pulmonary Arterial Hypertension: A Case Report. Indian Journal of Pharmacy Practice, 15(4), 338-341. https://doi.org/10.5530/ijopp.15.4.62

    Copyright and licence

    © 2022 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0